Source link : https://newshealth.biz/health-news/fresh-data-bolster-tyk2-blocker-for-psoriatic-arthritis/
(MedPage Today) — BARCELONA — The oral drug deucravacitinib (Sotyktu) passed what is probably its final test as a treatment for psoriatic arthritis (PsA), demonstrating superiority over placebo for most of its endpoints, according to a presentation… Source link : https://www.medpagetoday.com/meetingcoverage/eular/116082 Author : Publish date : 2025-06-14 20:15:00 Copyright for syndicated content belongs to the […]
The post Fresh Data Bolster TYK2 Blocker for Psoriatic Arthritis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-14 20:15:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8